Literature DB >> 23443311

Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis.

Antoine G Schneider1, Rinaldo Bellomo, Sean M Bagshaw, Neil J Glassford, Serigne Lo, Min Jun, Alan Cass, Martin Gallagher.   

Abstract

PURPOSE: Choice of renal replacement therapy (RRT) modality may affect renal recovery after acute kidney injury (AKI). We sought to compare the rate of dialysis dependence among severe AKI survivors according to the choice of initial renal replacement therapy (RRT) modality applied [continuous (CRRT) or intermittent (IRRT)].
METHODS: Systematic searches of peer-reviewed publications in MEDLINE and EMBASE were performed (last update July 2012). All studies published after 2000 reporting dialysis dependence among survivors from severe AKI requiring RRT were included. Data on follow-up duration, sex, age, chronic kidney disease, illness severity score, vasopressors, and mechanical ventilation were extracted when available. Results were pooled using a random-effects model.
RESULTS: We identified 23 studies: seven randomized controlled trials (RCTs) and 16 observational studies involving 472 and 3,499 survivors, respectively. Pooled analyses of RCTs showed no difference in the rate of dialysis dependence among survivors (relative risk, RR 1.15 [95 % confidence interval (CI) 0.78-1.68], I(2) = 0 %). However, pooled analyses of observational studies suggested a higher rate of dialysis dependence among survivors who initially received IRRT as compared with CRRT (RR 1.99 [95 % CI 1.53-2.59], I (2) = 42 %). These findings were consistent with adjusted analyses (performed in 7/16 studies), which found a higher rate of dialysis dependence in IRRT-treated patients [odds ratio (OR) 2.2-25 (5 studies)] or no difference (2 studies).
CONCLUSIONS: Among AKI survivors, initial treatment with IRRT might be associated with higher rates of dialysis dependence than CRRT. However, this finding largely relies on data from observational trials, potentially subject to allocation bias, hence further high-quality studies are necessary.

Entities:  

Mesh:

Year:  2013        PMID: 23443311     DOI: 10.1007/s00134-013-2864-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  86 in total

1.  Relationship between illness severity scores in acute kidney injury.

Authors:  Antoine G Schneider; Miklós Lipcsey; Michael Bailey; David V Pilcher; Rinaldo Bellomo
Journal:  Crit Care Resusc       Date:  2012-03       Impact factor: 2.159

Review 2.  The economics of renal failure and kidney disease in critically ill patients.

Authors:  Amay Parikh; Andrew Shaw
Journal:  Crit Care Clin       Date:  2012-01       Impact factor: 3.598

Review 3.  Continuous versus intermittent treatment: clinical results in acute renal failure.

Authors:  H Kierdorf
Journal:  Contrib Nephrol       Date:  1991       Impact factor: 1.580

4.  Incidence- and mortality-related risk factors of acute kidney injury requiring hemofiltration treatment in patients undergoing cardiac surgery: a single-center 6-year experience.

Authors:  Maciej M Kowalik; Romuald Lango; Katarzyna Klajbor; Violetta Musiał-Światkiewicz; Magdalena Kołaczkowska; Rafał Pawlaczyk; Jan Rogowski
Journal:  J Cardiothorac Vasc Anesth       Date:  2011-02-26       Impact factor: 2.628

5.  Renal recovery after severe acute renal failure.

Authors:  S M Bagshaw; G Mortis; T Godinez-Luna; C J Doig; K B Laupland
Journal:  Int J Artif Organs       Date:  2006-11       Impact factor: 1.595

6.  Predicting outcomes in critically ill patients with acute kidney injury undergoing intermittent hemodialysis--a retrospective cohort analysis.

Authors:  Daniel Franzen; Cornelia Rupprecht; Dimitri Hauri; Jorg A Bleisch; Max Staubli; Milo A Puhan
Journal:  Int J Artif Organs       Date:  2010-01       Impact factor: 1.595

7.  Epidemiology and prognostic factors of critically ill patients treated with hemodiafiltration.

Authors:  Stéphane Soubrier; Olivier Leroy; Patrick Devos; Saad Nseir; Hugues Georges; Thibaud d'Escrivan; Benoit Guery
Journal:  J Crit Care       Date:  2006-03       Impact factor: 3.425

8.  A comparison of continuous renal replacement therapy to intermittent dialysis in the management of renal insufficiency in the acutely III surgical patient.

Authors:  Jimmy Waldrop; David L Ciraulo; Timothy P Milner; Douglas Gregori; Aaron S Kendrick; Charles M Richart; Robert A Maxwell; Donald E Barker
Journal:  Am Surg       Date:  2005-01       Impact factor: 0.688

9.  Continuous renal replacement therapy improves renal recovery from acute renal failure.

Authors:  Michael J Jacka; Xenia Ivancinova; R T Noel Gibney
Journal:  Can J Anaesth       Date:  2005-03       Impact factor: 5.063

10.  The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods.

Authors:  Alan S Go; Chirag R Parikh; T Alp Ikizler; Steven Coca; Edward D Siew; Vernon M Chinchilli; Chi-Yuan Hsu; Amit X Garg; Michael Zappitelli; Kathleen D Liu; W Brian Reeves; Nasrollah Ghahramani; Prasad Devarajan; Georgia Brown Faulkner; Thida C Tan; Paul L Kimmel; Paul Eggers; John B Stokes
Journal:  BMC Nephrol       Date:  2010-08-27       Impact factor: 2.388

View more
  79 in total

1.  Does this patient with AKI need RRT?

Authors:  Miet Schetz; Lui G Forni; Michael Joannidis
Journal:  Intensive Care Med       Date:  2015-12-21       Impact factor: 17.440

2.  Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.

Authors:  Claire Roger; Steven C Wallis; Laurent Muller; Gilbert Saissi; Jeffrey Lipman; Jean-Yves Lefrant; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

3.  Continous renal replacement therapy and intermittent hemodialysis in acute kidney injury: equivalent or complementary?

Authors:  R T Noel Gibney
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  The Pattern of Longitudinal Change in Serum Creatinine and 90-Day Mortality After Major Surgery.

Authors:  Dmytro Korenkevych; Tezcan Ozrazgat-Baslanti; Paul Thottakkara; Petar Momcilovic; Azra Bihorac; Charles E Hobson; Panos Pardalos
Journal:  Ann Surg       Date:  2016-06       Impact factor: 12.969

Review 5.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

Review 6.  Prolonged intermittent renal replacement therapy in children.

Authors:  Rajiv Sinha; Sidharth Kumar Sethi; Timothy Bunchman; Valentine Lobo; Rupesh Raina
Journal:  Pediatr Nephrol       Date:  2017-07-18       Impact factor: 3.714

Review 7.  Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.

Authors:  Ying Wang; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

Review 8.  Fluid management for the prevention and attenuation of acute kidney injury.

Authors:  John R Prowle; Christopher J Kirwan; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

Review 9.  [Extracorporeal renal replacement therapy in acute kidney injury : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  V Schwenger; D Kindgen-Milles; C Willam; A Jörres; W Druml; D Czock; S J Klein; M Oppert; M Schmitz; J T Kielstein; A Zarbock; M Joannidis; S John
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-03-15       Impact factor: 0.840

10.  A patient with AKI after cardiac surgery.

Authors:  Ashita J Tolwani
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.